Literature DB >> 19604432

The epidemiology of primary systemic vasculitides involving small vessels in Crete (southern Greece): a comparison of older versus younger adult patients.

S H Panagiotakis1, G S Perysinakis, H Kritikos, D Vassilopoulos, G Vrentzos, M Linardakis, G Bertsias, K Glaser, E Daphnis, D T Boumpas.   

Abstract

BACKGROUND: The frequency of primary systemic small vessel vasculitides (PSV) varies among different geographic regions and age categories. We studied PSV in patients from middle-eastern Crete (Greece), and compared clinical characteristics in younger (<65 years) versus older (> or = 65 years) adult patients.
METHODS: The records of 67 patients (33 younger, 34 older adults) diagnosed with PSV during 1995-2003 who were referred to a mixed secondary/tertiary care University Hospital in Crete were reviewed. Data on clinical manifestations, diagnosis, therapy, and adverse outcomes (end stage renal disease, death) during a median follow-up of 6 (range 0-12) years were recorded. Multivariate regression analysis was applied to identify independent predictors for adverse outcomes.
RESULTS: The overall annual incidence of PSV was 19.5/million (95% confidence interval [CI] 15.7-23.4), 48.9/million (95% CI 33.8-63.9) in older and 12.4/million (95% CI 7.7-17) in younger adults. Microscopic polyangiitis was more prevalent in older patients (65%) and Wegener's Granulomatosis in younger patients (52%). Thirty-one percent of older patients developed end-stage renal disease as compared to 11% of younger patients (p=0.103). Mortality rates were 60% in older patients and 19% in younger patients (p=0.001). In multivariate regression analysis age (Beta=0.33 per 1-year, p=0.005), serum creatinine (Beta=0.29 per 1-mg/dL, p=0.011), and lung involvement (Beta=0.36, p=0.002) at the time of diagnosis were independent predictors for end stage renal disease and/or death.
CONCLUSION: This study documents increased frequency and significant mortality of PSV among older people in Crete, with MPA being the most prevalent type. Age, serum creatinine, and lung involvement are important predictors for adverse outcome in these patients.

Entities:  

Mesh:

Year:  2009        PMID: 19604432

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  5 in total

1.  Intravenous cyclophosphamide and plasmapheresis in dialysis-dependent ANCA-associated vasculitis.

Authors:  Ruth J Pepper; Dimitrios Chanouzas; Ruth Tarzi; Mark A Little; Alina Casian; Alina Caisian; Michael Walsh; Charles D Pusey; Lorraine Harper; Alan D Salama
Journal:  Clin J Am Soc Nephrol       Date:  2012-11-15       Impact factor: 8.237

2.  Systematic Review and Metaanalysis of Worldwide Incidence and Prevalence of Antineutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis.

Authors:  Rocío Redondo-Rodriguez; Natalia Mena-Vázquez; Alba María Cabezas-Lucena; Sara Manrique-Arija; Arkaitz Mucientes; Antonio Fernández-Nebro
Journal:  J Clin Med       Date:  2022-05-04       Impact factor: 4.964

3.  The epidemiology of antineutrophil cytoplasmic antibody-associated vasculitis in northwestern Turkey.

Authors:  Ömer Nuri Pamuk; Salim Dönmez; Gökçe Büşra Calayır; Gülsüm Emel Pamuk
Journal:  Clin Rheumatol       Date:  2016-03-18       Impact factor: 2.980

4.  Clinical features and outcome of microscopic polyangiitis under a new consensus algorithm of ANCA-associated vasculitides in Korea.

Authors:  Joong Kyong Ahn; Ji-Won Hwang; Jaejoon Lee; Chan Hong Jeon; Hoon-Suk Cha; Eun-Mi Koh
Journal:  Rheumatol Int       Date:  2011-09-07       Impact factor: 3.580

5.  Intense immunostaining of heat shock protein 70 within renal interstitium associates with long-term renal survival in an ANCA-associated vasculitis cohort.

Authors:  Ioannis Petrakis; Ariadni Androvitsanea; Stavros Stratakis; Eugene Daphnis; Kostas Stylianou
Journal:  Cell Stress Chaperones       Date:  2020-09-02       Impact factor: 3.667

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.